Table 2.
Maternal hemodynamics control and neonatal outcome in patients with PPP (n = 33)
| ‘ | GroupA (n = 17) | GroupB (n = 16) | P value |
|---|---|---|---|
| Intraoperative application of vasopressor | 7 (41.2%) | 12 (75%) | 0.080 |
| Hysterectomy | 3 (17.6%) | 2 (12.5%) | 1.000 |
| Postoperative uterine artery embolism | 0 | 5 (31.3%) | 0.018* |
| Postoperative ICU admission | 7 (41.2%) | 8 (50%) | 0.494 |
| Neonatal weight(g) | 2638.24 ± 346.07 | 2580.31 ± 503.58 | 0.071 |
| APGAR 1MIN(score) | 8.94 ± 1.43 | 9.81 ± 0.75 | 0.037# |
| APGAR 5MIN(score) | 9.82 ± 0.39 | 9.94 ± 0.25 | 0.326 |
| APGAR10MIN(score) | 9.88 ± 0.33 | 10.00 ± 0.00 | 0.163 |
PPP pernicious placenta previa
#p-value less than 0.05 was considered statistically significant